Mark Ogden
2009
In 2009, Mark Ogden earned a total compensation of $330.6K as Acting Vice President, Finance and Principal Financial Officer at Enzon Pharmaceuticals, a 6% decrease compared to previous year.
Compensation breakdown
| Other | $330,607 |
|---|---|
| Total | $330,607 |
Ogden received $330.6K in other compensation, accounting for 100% of the total pay in 2009.
Rankings
In 2009, Mark Ogden's compensation ranked 8,117th out of 9,885 executives tracked by ExecPay. In other words, Ogden earned more than 17.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,117 out of 9,885 | 18th |
Division Manufacturing | 3,048 out of 3,690 | 17th |
Major group Chemicals And Allied Products | 704 out of 866 | 19th |
Industry group Drugs | 507 out of 638 | 21st |
Industry Biological Products, Except Diagnostic Substances | 91 out of 133 | 32nd |
Source: SEC filing on April 8, 2011.
Ogden's colleagues
We found five more compensation records of executives who worked with Mark Ogden at Enzon Pharmaceuticals in 2009.
2009
Jeffrey Buchalter
Enzon Pharmaceuticals
Chief Executive Officer
2009
Ivan Horak
Enzon Pharmaceuticals
Chief Scientific Officer
2009
Craig Tooman
Enzon Pharmaceuticals
Chief Financial Officer
2009
Ralph del Campo
Enzon Pharmaceuticals
Chief Operating Officer
2009
Paul Davit
Enzon Pharmaceuticals